Subscribe now

Comment and Health

Nice prize for Alzheimer's work, shame about the lack of a cure

The prestigious annual Brain prize has gone to work on Alzheimer's disease. That's fine, but the failure to find new treatments is worrying

By Jacqui Wise

6 March 2018

Artwork showing different ways of visualising the brain

Alfred Pasieka/Science Photo Library

Alzheimer’s disease is back in the headlines with the announcement that the annual €1 million Brain prize has gone to four neuroscientists researching the genetic and molecular basis of the illness.

This is recognition of great basic science. John Hardy at University College London (UCL) was the first to propose that Alzheimer’s disease was initiated by the build-up of beta amyloid, a protein that can coagulate into plaques that kill brain cells. Michel Goedert at the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK, was instrumental in the discovery of the importance of tau protein, which also…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

Popular articles

Trending New Scientist articles

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop